B of A Securities analyst Doug Leggate upgrades HollyFrontier (NYSE:HFC) from Neutral to Buy.
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/8/2022 | Neutral → Buy | B of A Securities | |
| 3/8/2022 | $40.00 → $47.00 | Neutral → Buy | BofA Securities |
| 2/24/2022 | $41.00 | Equal-Weight → Overweight | Wells Fargo |
| 1/12/2022 | $48.00 → $44.00 | Overweight | Morgan Stanley |
| 1/4/2022 | $33.00 → $37.00 | Equal-Weight | Barclays |
| 12/28/2021 | $32.00 → $34.00 | Market Perform | Cowen & Co. |
| 11/8/2021 | $42.00 → $44.00 | Outperform | Credit Suisse |
| 10/6/2021 | $31.00 → $35.00 | Equal-Weight | Wells Fargo |
4 - HollyFrontier Corp (0000048039) (Issuer)
4 - HollyFrontier Corp (0000048039) (Issuer)
4 - HollyFrontier Corp (0000048039) (Issuer)
S-8 POS - HollyFrontier Corp (0000048039) (Filer)
S-8 POS - HollyFrontier Corp (0000048039) (Filer)
S-8 POS - HollyFrontier Corp (0000048039) (Filer)
SC 13G - HollyFrontier Corp (0000048039) (Subject)
SC 13G/A - HollyFrontier Corp (0000048039) (Subject)
SC 13G - HollyFrontier Corp (0000048039) (Subject)
B of A Securities upgraded HollyFrontier from Neutral to Buy
BofA Securities upgraded HollyFrontier from Neutral to Buy and set a new price target of $47.00 from $40.00 previously
Wells Fargo upgraded HollyFrontier from Equal-Weight to Overweight and set a new price target of $41.00
Reported net income attributable to HollyFrontier stockholders of $558.3 million or $3.39 per diluted share and adjusted net income of $250.1 million or $1.52 per diluted share, for the year Reported EBITDA of $1,306.9 million and adjusted EBITDA of $915.7 million, for the year HollyFrontier Corporation (NYSE:HFC) ("HollyFrontier" or the "Company") today reported fourth quarter net loss attributable to HollyFrontier stockholders of $(39.5) million or $(0.24) per diluted share for the quarter ended December 31, 2021, compared to $(117.7) million or $(0.73) per diluted share for the quarter ended December 31, 2020. The fourth quarter results reflect special items that collectively incr
Reported net income attributable to HollyFrontier stockholders of $280.8 million, or $1.71 per diluted share, and adjusted net income of $209.9 million, or $1.28 per diluted share, for the third quarter Reported EBITDA of $482.6 million and Adjusted EBITDA of $407.8 million for the third quarter HollyFrontier Corporation (NYSE:HFC) ("HollyFrontier" or the "Company") today reported third quarter net income attributable to HollyFrontier stockholders of $280.8 million, or $1.71 per diluted share, for the quarter ended September 30, 2021, compared to a net loss of $(2.4) million, or $(0.01) per diluted share, for the quarter ended September 30, 2020. The third quarter results reflect spe
Reported net income attributable to HollyFrontier stockholders of $168.9 million, or $1.03 per diluted share, and adjusted net income of $143.0 million, or $0.87 per diluted share, for the second quarter Reported EBITDA of $444.3 million and Adjusted EBITDA of $334.5 million for the second quarter HollyFrontier Corporation (NYSE:HFC) ("HollyFrontier" or the "Company") today reported second quarter net income attributable to HollyFrontier stockholders of $168.9 million, or $1.03 per diluted share, for the quarter ended June 30, 2021, compared to a net loss of $(176.7) million, or $(1.09) per diluted share, for the quarter ended June 30, 2020. The second quarter results reflect special
HF Sinclair Corporation Established as a Leading Integrated Downstream Petroleum and Renewable Fuels Company HollyFrontier Corporation (NYSE:HFC) ("HollyFrontier") and Holly Energy Partners, L.P. (NYSE:HEP) ("HEP"), today announced the establishment of HF Sinclair Corporation (NYSE:DINO) ("HF Sinclair") as the new parent holding company of HollyFrontier and HEP and the completion of their respective acquisitions of Sinclair Oil Corporation and Sinclair Transportation Company from The Sinclair Companies. Commencing at market open on March 15, 2022, HF Sinclair will replace HollyFrontier as the public company trading on the New York Stock Exchange, and will trade under the ticker symbol "DIN
Reported net income attributable to HollyFrontier stockholders of $558.3 million or $3.39 per diluted share and adjusted net income of $250.1 million or $1.52 per diluted share, for the year Reported EBITDA of $1,306.9 million and adjusted EBITDA of $915.7 million, for the year HollyFrontier Corporation (NYSE:HFC) ("HollyFrontier" or the "Company") today reported fourth quarter net loss attributable to HollyFrontier stockholders of $(39.5) million or $(0.24) per diluted share for the quarter ended December 31, 2021, compared to $(117.7) million or $(0.73) per diluted share for the quarter ended December 31, 2020. The fourth quarter results reflect special items that collectively incr
HollyFrontier Corporation (NYSE:HFC) (the "Company") plans to announce results for its quarter ending December 31, 2021 on February 23, 2022, before the opening of trading on the NYSE. The Company has scheduled a webcast conference on February 23, 2022 at 8:30 a.m. Eastern time to discuss financial results. This webcast may be accessed at: https://events.q4inc.com/attendee/868741482 An audio archive of this webcast will be available using the above noted link through March 9, 2022. About HollyFrontier Corporation: HollyFrontier Corporation, headquartered in Dallas, Texas, is an independent petroleum refiner and marketer that produces high value light products such as gasoline, diesel f
Wells Fargo cut the price target on Coupa Software Incorporated (NYSE:LPI) from $190 to $80. Laredo Petroleum shares fell 29.8% to $63.10 in pre-market trading. Credit Suisse raised HollyFrontier Corporation (NYSE:HFC) price target from $44 to $50. HollyFrontier shares fell 0.2% to $36.33 in pre-market trading. Raymond James cut the price target on EverCommerce Inc. (NASDAQ:EVCM) from $24 to $17. EverCommerce shares fell 1.6% to $12.02 in pre-market trading. Barclays boosted the price target for Ulta Beauty, Inc. (NASDAQ:ULTA) from $440 to $469. Ulta Beauty shares rose 0.3% to $358.50 in pre-market trading. SVB Leerink cut Nektar Therapeutics (NASDAQ:NKTR) price target from $
Credit Suisse analyst Manav Gupta maintains HollyFrontier (NYSE:HFC) with a Outperform and raises the price target from $44 to $50.